Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56
European Journal of Dermatology · 2023
DOI: 10.1684/ejd.2023.4583 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Dermatology, 2023. Verfasst von Aiko Kobayashi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Cutaneous, Skin Neoplasms, Lymphoma, Extranodal NK-T-Cell.
Abstract (Originalsprache)
BackgroundSarcoidosis is a systemic disease that affects the skin in about 25% of patients. The treatment of cutaneous sarcoidosis is guided by the extent of lesions, associated symptoms and organ involvement.ObjectivesTo evaluate rates of response to various potential first-line treatments for cutaneous sarcoidosis during the year following treatment initiation.Materials & MethodsThis retrospective multicentre study included 120 patients with cutaneous sarcoidosis. Treatment response was assessed retrospectively from the patients’ medical records. Univariate logistic regression analysis, with an estimation of unadjusted odds ratios (OR) and their 95% CI,was performed to identify factors associated with complete cutaneous remission (CR), followed by multivariate logistic regression analysis.ResultsAt one year, 43 of the 120 (36%) included patients had CR. The best response rates were obtained with oral corticosteroids (12/21, 57%), followed by a combination of hydroxychloroquine and topical steroids (6/13, 46%). In multivariate analysis, lupus pernio was the only predictor of a poor cutaneous response.ConclusionWe suggest the use of a combination of hydroxychloroquine and topical steroids as an optimal first-line treatment for cutaneous sarcoidosis, given the known adverse effects of systemic corticosteroids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and.
- Department of Pathology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Zitieren
APA
Kobayashi, A., Goto, H., Negishi-Asano, A., Sowa-Osako, J., Tanaka, S., Ohe, C., Kohashi, K., Tsuruta, D., & Tateishi, C. (2023). Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56. European Journal of Dermatology. https://doi.org/10.1684/ejd.2023.4583
Vancouver
Kobayashi A, Goto H, Negishi-Asano A, Sowa-Osako J, Tanaka S, Ohe C, et al. Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56. European Journal of Dermatology. 2023. doi:10.1684/ejd.2023.4583
BibTeX
@article{Kobayashi2023,
author = {Kobayashi, Aiko and Goto, Hiroyuki and Negishi-Asano, Airi and Sowa-Osako, Junko and Tanaka, Sayaka and Ohe, Chisato and Kohashi, Kenichi and Tsuruta, Daisuke and Tateishi, Chiharu},
title = {Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56},
journal = {European Journal of Dermatology},
year = {2023},
doi = {10.1684/ejd.2023.4583}
}
EUVIMED